NeuroVive Pharmaceutical AB SMA 50
What is the SMA 50 of NeuroVive Pharmaceutical AB?
The SMA 50 of NeuroVive Pharmaceutical AB is $0 +0.00%
What is the definition of SMA 50?
SMA 50 is an average stock price from the last 50 days calculated as an unweighted mean of the previous 50 stock closing prices.
Simple moving average of 50 days for a stock is an unweighted moving average over the past 50 days. Moving averages will always exhibit a lag and the longer the period used for averaging the greater the lag will be. Because of the large amounts of data considered when calculating a long-term moving average, it takes a considerable amount of movement in the market to cause the moving average to change its course.
Using a moving average to confirm a trend in price is one of the most basic, yet effecting ways of using the indicator. Moving averages take into account what has already happened and a whole range of past events, which makes them such a good technical analysis tool for trend confirmations. Generally, a long-term moving average that is clearly on the upswing is a confirmation of a bullish trend. Conversely, a long-term moving average that is clearly on the downswing is a confirmation of a bearish trend.
SMA 50 of companies in the Health Care sector on OTC compared to NeuroVive Pharmaceutical AB
What does NeuroVive Pharmaceutical AB do?
Abliva AB (publ), a pharmaceutical company, engages in the research and development of mitochondrial medicine. The company is developing KL1333 that is in Phase I clinical trials for the chronic treatment of primary mitochondrial diseases; NV354, which is in the preparation for clinical trials for the treatment of primary mitochondrial diseases with Complex I deficiency; and NeuroSTAT for traumatic brain injury. It has collaboration agreements with Isomerase, Yungjin Pharm, University of Pennsylvania, Children's Hospital of Philadelphia, Patheon, and Oroboros Instruments. The company was formerly known as NeuroVive Pharmaceutical AB (publ) and changed its name to Abliva AB (publ) in May 2020. Abliva AB (publ) was incorporated in 2000 and is headquartered in Lund, Sweden.
Companies with sma 50 similar to NeuroVive Pharmaceutical AB
- Enerev5 Metals has SMA 50 of CAD$0 -93.75%
- Monarca Minerals has SMA 50 of CAD$0 -93.75%
- Sorrento Therapeutics Inc has SMA 50 of $0 +3.13%
- AusCann has SMA 50 of $0 -155.18%
- Auris Minerals has SMA 50 of AUD$0 -94.12%
- Surefire Resources NL has SMA 50 of AUD$0 -38.89%
- NeuroVive Pharmaceutical AB has SMA 50 of $0 +0.00%
- Forbidden Foods has SMA 50 of $0 +6.49%
- Accelerate Resources has SMA 50 of AUD$0 -14.58%
- Rodedawg International Industries has SMA 50 of $0 -71.88%
- E2Gold has SMA 50 of CAD$0 -3.85%
- Propell Ltd has SMA 50 of $0 +18.68%
- Shanghai Zendai Property has SMA 50 of HKD$0 +18.41%